Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18915848 | FACIAL BEAUTY MASK | October 2024 | March 2025 | Allow | 5 | 1 | 0 | No | No |
| 18661059 | MODULAR IMPLANT DELIVERY AND POSITIONING SYSTEM | May 2024 | January 2025 | Allow | 8 | 1 | 0 | Yes | No |
| 18611522 | REAL-TIME TRACKING OF CEREBRAL HEMODYNAMIC RESPONSE (RTCHR) OF A SUBJECT BASED ON HEMODYNAMIC PARAMETERS | March 2024 | August 2025 | Abandon | 17 | 1 | 0 | No | No |
| 18441083 | APPARATUS, SYSTEM AND METHOD FOR CHRONIC DISEASE MONITORING | February 2024 | June 2025 | Allow | 16 | 1 | 0 | No | No |
| 18407397 | LOW POWER RECEIVER FOR IN VIVO CHANNEL SENSING AND INGESTIBLE SENSOR DETECTION WITH WANDERING FREQUENCY | January 2024 | June 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18511752 | IMAGE GUIDED VARIABLE SPOT STIMULATION-BASED ELECTROPHYSIOLOGY ASSESSMENT DEVICE TO DETERMINE CHANGES IN THE FUNCTIONAL HEALTH OF BIOLOGICAL SAMPLES DURING DISEASE PROGRESSION AND THERAPY | November 2023 | November 2024 | Allow | 12 | 1 | 0 | Yes | No |
| 18492038 | SENSING FOR HEART FAILURE MANAGEMENT | October 2023 | June 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18365248 | ADJUVANT NAIL TREATMENT DEVICE | August 2023 | March 2025 | Allow | 19 | 3 | 0 | No | No |
| 18212207 | BLOOD PUMP SYSTEM | June 2023 | April 2024 | Allow | 10 | 1 | 0 | No | No |
| 18296045 | WEARABLE PHYSIOLOGICAL MONITORING SYSTEMS AND METHODS | April 2023 | December 2025 | Allow | 33 | 5 | 0 | Yes | No |
| 18116299 | Variable Human-Safe Electromagnetic Radiation Therapy Systems and Methods | March 2023 | March 2026 | Abandon | 37 | 1 | 0 | No | No |
| 18145426 | CONTROL DEVICE AND METHOD FOR A HEART PUMP | December 2022 | August 2024 | Allow | 20 | 2 | 0 | No | No |
| 17982086 | NEUROANAL YTIC, NEURODIAGNOSTIC, AND THERAPEUTIC TOOLS | November 2022 | April 2024 | Allow | 18 | 1 | 0 | Yes | No |
| 17997951 | BLACK LIGHT DEVICE FOR IMPROVING VITAMIN D3 FORMATION IN ANIMALS AND INACTIVATING BACTERIA AND VIRUSES | November 2022 | December 2025 | Abandon | 38 | 2 | 0 | No | No |
| 17977413 | SYSTEMS AND METHODS FOR PRESERVING AND/OR ENHANCING RESPIRATORY FUNCTION | October 2022 | January 2026 | Allow | 39 | 1 | 0 | No | No |
| 17972557 | METHODS OF SKIN TREATMENT WITH LASER LIGHT | October 2022 | February 2025 | Allow | 28 | 4 | 0 | Yes | No |
| 17971162 | System for Managing Personal Health Regimens based on Continuously-Adjusted Incentives | October 2022 | July 2024 | Abandon | 21 | 1 | 0 | No | No |
| 17996721 | CONFIGURABLE OPTICAL APPLICATOR | October 2022 | February 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 17910076 | SYSTEMS AND METHODS FOR ESTIMATING CARDIAC ARRYTHMIA | September 2022 | September 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17909870 | CONTROLLING CYTOCHROME C OXIDASE OF A LIGHT SOURCE BASED ON UV IRRADIATION AMOUNT | September 2022 | December 2024 | Allow | 28 | 0 | 0 | No | No |
| 17929125 | FACE MASK | September 2022 | July 2025 | Allow | 34 | 2 | 0 | Yes | No |
| 17896599 | LASER IRRADIATION DEVICE | August 2022 | February 2025 | Allow | 30 | 0 | 0 | No | No |
| 17893104 | LIGHT THERAPY TREATMENT MODALITY WITH OSCILLATING AND NONOSCILLATING WAVELENGTHS | August 2022 | August 2025 | Allow | 36 | 0 | 1 | Yes | No |
| 17892562 | PHOTOTHERAPY CAP AND LINING THEREOF | August 2022 | April 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17889105 | MEDICAL DEVICE AND METHOD OF OPERATING A MEDICAL DEVICE | August 2022 | September 2025 | Abandon | 37 | 2 | 0 | Yes | No |
| 17867822 | LIGHT THERAPY WEARABLE | July 2022 | December 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17865820 | MULTI-MODAL SLEEP SYSTEM | July 2022 | January 2025 | Allow | 30 | 5 | 0 | Yes | No |
| 17861646 | EXTERNAL AUDITORY CANAL THERAPY DEVICE | July 2022 | July 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17811387 | WEARABLE LIGHT STIMULATION SYSTEMS AND METHODS | July 2022 | January 2023 | Allow | 7 | 2 | 0 | Yes | No |
| 17781021 | SYSTEMS AND METHODS OF PROVIDING NETWORKS BASED ON TEXTILES | May 2022 | May 2025 | Allow | 35 | 2 | 0 | Yes | No |
| 17747530 | NECK-HANGING MASSAGING DEVICE | May 2022 | August 2023 | Allow | 15 | 1 | 0 | Yes | No |
| 17747588 | NECK-HANGING MASSAGING DEVICE | May 2022 | May 2023 | Allow | 12 | 1 | 0 | No | No |
| 17747567 | NECK-HANGING MASSAGING DEVICE | May 2022 | June 2023 | Allow | 13 | 1 | 0 | Yes | No |
| 17744591 | PHOTOTHERAPY | May 2022 | April 2024 | Abandon | 23 | 3 | 1 | Yes | No |
| 17739020 | ANTENNA ARRANGEMENT FOR WRIST-WORN TRAINING COMPUTER | May 2022 | June 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17737955 | PHOTOBIOMODULATION METHOD AND SYSTEM FOR INDUCING ACTIVITY OF BRAINDERIVED NERVE GROWTH FACTOR IN HIPPOCAMPAL TISSUE | May 2022 | January 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17714269 | Wearable Light Therapy Device | April 2022 | June 2023 | Allow | 14 | 4 | 0 | Yes | No |
| 17754348 | Glove for detecting multiple physiological parameters and system for detecting risk of hypertension disease | March 2022 | March 2024 | Abandon | 24 | 2 | 0 | No | No |
| 17708001 | BIOLOGICAL INFORMATION MONITORING SYSTEM | March 2022 | August 2025 | Allow | 40 | 2 | 0 | Yes | No |
| 17655902 | PHOTOPLETHYSMOGRAPHY DERIVED BLOOD PRESSURE MEASUREMENT CAPABILITY | March 2022 | December 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17690866 | REAL-TIME METHODS TO ENABLE PRECISION-GUIDED CPR TO IMPROVE NEUROLOGICAL OUTCOME AND PREDICT BRAIN DAMAGE AFTER ISCHEMIC INJURY AND REPERFUSION | March 2022 | January 2025 | Allow | 34 | 0 | 1 | Yes | No |
| 17635566 | PHOTOTHERAPY DEVICE AND METHOD OF OPERATION OF PHOTOTHERAPY DEVICE | February 2022 | June 2025 | Allow | 39 | 2 | 0 | No | No |
| 17634310 | APPARATUS FOR PROCESSING SENSOR SIGNALS | February 2022 | September 2025 | Abandon | 43 | 2 | 0 | Yes | No |
| 17649709 | Penis phototherapy device | February 2022 | March 2025 | Allow | 38 | 1 | 0 | Yes | No |
| 17589082 | EXTERNAL AUDITORY CANAL PHOTOBIOMODULATION AND AUDIO THERAPY DEVICE | January 2022 | August 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17562185 | METHOD FOR PROVIDING CONTROL DATA OF AN EYE SURGICAL LASER OF A TREATMENT APPARATUS BASED ON A PATIENT-SPECIFIC PARAMETER SET; CONTROL DEVICE AS WELL AS TREATMENT APPARATUS | December 2021 | May 2025 | Allow | 41 | 2 | 0 | Yes | No |
| 17561260 | CONTROLLED POSITION ELECTRODE ARRAY | December 2021 | August 2024 | Allow | 32 | 3 | 0 | Yes | No |
| 17645747 | CONFOCAL LASER EYE SURGERY SYSTEM | December 2021 | March 2024 | Allow | 27 | 2 | 0 | No | No |
| 17558832 | VFA CARDIAC RESYNCHRONIZATION THERAPY | December 2021 | September 2023 | Allow | 20 | 2 | 0 | No | No |
| 17554455 | ADHESIVE PAD WITH A METALLIC COIL FOR SECURING AN ON-BODY MEDICAL DEVICE | December 2021 | June 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17546650 | APPARATUS AND METHOD FOR TREATING SKIN LESIONS | December 2021 | May 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17617364 | EXTERNAL AUDITORY CANAL PHOTOBIOMODULATION DEVICE | December 2021 | July 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17600647 | DEVICE FOR BIOSTIMULATING PHOTOTHERAPHY | October 2021 | June 2025 | Allow | 45 | 3 | 0 | Yes | No |
| 17593559 | SKIN TREATMENT METHOD USING MEDICAL LASER, HAVING IMPROVED TREATMENT EFFICACY | September 2021 | December 2025 | Abandon | 51 | 3 | 0 | No | No |
| 17439050 | WEARABLE DEVICE FOR PAIN TREATMENT BY COMPOUND PHOTO-CHEMICAL ACTION PRINCIPLE | September 2021 | April 2025 | Allow | 43 | 1 | 0 | Yes | No |
| 17436135 | MASK AND SKIN CARE DEVICE INCLUDING SAME | September 2021 | March 2025 | Allow | 43 | 1 | 0 | Yes | No |
| 17446703 | WEARABLE LIGHT STIMULATION SYSTEMS AND METHODS | September 2021 | November 2022 | Abandon | 15 | 2 | 0 | No | No |
| 17310776 | OPTICAL APPLICATOR FEATURE OPTIMIZER | August 2021 | January 2024 | Allow | 29 | 1 | 0 | No | No |
| 17382275 | DISPLAYS WITH THERAPEUTIC-LIGHT EMITTERS AND METHODS OF THEIR USE | July 2021 | January 2026 | Abandon | 54 | 2 | 1 | No | No |
| 17377123 | PORTABLE DEVICE FOR QUANTITATIVE MEASUREMENT OF TISSUE AUTOREGULATION AND NEUROVASCULAR COUPLING USING EEG, METABOLISM, AND BLOOD FLOW DIAGNOSTICS | July 2021 | September 2024 | Allow | 39 | 0 | 1 | Yes | No |
| 17347182 | PATIENT SUPPORT APPARATUS WITH PATIENT INFORMATION SENSORS | June 2021 | July 2025 | Allow | 49 | 4 | 0 | Yes | Yes |
| 17303960 | SYSTEMS AND METHODS FOR SYNCHRONIZED THREE-DIMENSIONAL LASER INCISIONS | June 2021 | March 2024 | Allow | 33 | 3 | 0 | No | No |
| 17339314 | LASER TREATMENT OF SKIN LESIONS UNDER DERMAL VASOCONSTRICTION | June 2021 | March 2024 | Allow | 33 | 2 | 0 | No | No |
| 17329633 | SYSTEMS FOR PERFORMING ENDOSCOPIC PROCEDURES | May 2021 | December 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17324011 | ENHANCING LEFT VENTRICULAR RELAXATION THROUGH NEUROMODULATION | May 2021 | December 2022 | Allow | 19 | 0 | 0 | Yes | No |
| 17236937 | CONFOCAL LASER EYE SURGERY SYSTEM | April 2021 | March 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17232036 | CARDIAC EVENT IDENTIFIER AND SELECTOR | April 2021 | November 2024 | Abandon | 43 | 4 | 0 | Yes | No |
| 17221415 | MODULATED WAVEFORM TREATMENT DEVICE AND METHOD | April 2021 | March 2024 | Allow | 35 | 2 | 0 | No | No |
| 17203308 | COMPONENTRY AND DEVICES FOR LIGHT THERAPY DELIVERY AND METHODS RELATED THERETO | March 2021 | May 2022 | Allow | 14 | 2 | 0 | Yes | No |
| 17196690 | MODULAR IMPLANT DELIVERY AND POSITIONING SYSTEM | March 2021 | February 2024 | Allow | 35 | 3 | 0 | No | No |
| 17267178 | DELIVERY OF ENERGY TO A TARGET REGION OF A PATIENT'S BODY TO SATISFY THERAPEUTIC REQUIREMENTS PRECISELY | February 2021 | June 2025 | Abandon | 52 | 5 | 0 | No | No |
| 17264927 | INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE | February 2021 | August 2024 | Allow | 42 | 1 | 0 | Yes | No |
| 17152263 | MULTI-MODAL SLEEP SYSTEM | January 2021 | December 2023 | Abandon | 35 | 2 | 0 | Yes | No |
| 17146849 | Methods and Systems for Activating Cells to Treat Aging | January 2021 | October 2023 | Allow | 33 | 2 | 0 | No | No |
| 17140655 | TEMPERATURE SENSING OF IMPLANTED WIRELESS RECHARGE COIL | January 2021 | December 2025 | Allow | 59 | 3 | 0 | Yes | No |
| 17131761 | BIOLOGICAL INFORMATION MONITORING SYSTEM | December 2020 | February 2024 | Allow | 38 | 1 | 0 | No | No |
| 17124718 | Determination Device | December 2020 | September 2023 | Allow | 33 | 3 | 0 | Yes | No |
| 17253357 | SYSTEMS AND METHODS FOR EVALUATION OF HEALTH SITUATION OR CONDITION | December 2020 | July 2024 | Allow | 43 | 1 | 0 | No | No |
| 17252600 | LOW POWER RECEIVER FOR IN VIVO CHANNEL SENSING AND INGESTIBLE SENSOR DETECTION WITH WANDERING FREQUENCY | December 2020 | September 2023 | Allow | 33 | 0 | 0 | No | No |
| 17252639 | RE-WEARABLE PHYSIOLOGICAL MONITORING DEVICE | December 2020 | December 2024 | Allow | 48 | 2 | 1 | Yes | No |
| 17106883 | MACRO/MICRO-STRUCTURE OF SLEEP AND SIMILAR STATES OF CONSCIOUSNESS TO OPTIMIZE PAIN TREATMENT | November 2020 | June 2023 | Allow | 30 | 2 | 0 | No | No |
| 17057721 | APPARATUS AND A METHOD FOR MONITORING A PATIENT DURING HIS SLEEP | November 2020 | May 2025 | Abandon | 54 | 6 | 0 | No | No |
| 17061073 | Method for predicting efficacy of a stimulus by measuring physiological response to stimuli | October 2020 | March 2024 | Abandon | 42 | 2 | 0 | Yes | No |
| 17042678 | ARM DEVICE | September 2020 | February 2025 | Allow | 53 | 2 | 0 | Yes | No |
| 16948292 | APPARATUS, SYSTEM AND METHOD FOR CHRONIC DISEASE MONITORING | September 2020 | November 2023 | Allow | 38 | 3 | 0 | Yes | No |
| 16978737 | Mid infrared radiation sauna | September 2020 | December 2023 | Abandon | 40 | 1 | 0 | No | No |
| 16989067 | Light Therapy Apparatus | August 2020 | December 2021 | Allow | 16 | 2 | 0 | Yes | No |
| 16985113 | PORTABLE DEVICE FOR QUANTITATIVE MEASUREMENT OF TISSUE AUTOREGULATION AND NEUROVASCULAR COUPLING USING EEG, METABOLISM, AND BLOOD FLOW DIAGNOSTICS | August 2020 | September 2021 | Abandon | 13 | 2 | 0 | Yes | No |
| 16966962 | OXYTOCIN RELEASE STIMULATION | August 2020 | December 2023 | Allow | 41 | 0 | 1 | No | No |
| 16960679 | System and Method for Classifying and Modulating Brain Behavioral States | July 2020 | December 2022 | Allow | 30 | 1 | 0 | Yes | No |
| 16958525 | SYNCHRONIZATION OF PHYSIOLOGICAL DATA | June 2020 | April 2024 | Allow | 46 | 5 | 0 | Yes | No |
| 16760442 | HEALTHCARE DEVICE AND HEALTHCARE SYSTEM USING SAME | June 2020 | July 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16865379 | DEVICE AND METHOD FOR FAST ACQUISITION OF VITAL SIGNS | May 2020 | September 2024 | Abandon | 53 | 4 | 0 | No | No |
| 16760806 | PHOTOBIOMODULATION THERAPY TO AMELIORATE MULTIPLE SCLEROSIS | April 2020 | June 2022 | Abandon | 25 | 4 | 0 | Yes | No |
| 16863664 | WEARABLE LIGHT STIMULATION SYSTEMS AND METHODS | April 2020 | May 2021 | Allow | 12 | 1 | 1 | No | No |
| 16861622 | DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY | April 2020 | May 2023 | Abandon | 36 | 3 | 0 | Yes | No |
| 16846551 | COMPRESSED-SENSING OF SPATIOTEMPORALLY-CORRELATED AND/OR RAKENESS-PROCESSED ELECTROGRAMS | April 2020 | October 2022 | Allow | 30 | 1 | 0 | No | No |
| 16753508 | A METHOD AND AN APPARATUS FOR PRODUCING INFORMATION INDICATIVE OF METABOLIC STATE | April 2020 | September 2022 | Abandon | 30 | 1 | 0 | No | No |
| 16840083 | AV SYNCHRONOUS VFA CARDIAC THERAPY | April 2020 | January 2026 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 16834770 | PHOTOTHERAPEUTIC DEVICE FOR A PENIS AND A USING METHOD THEREOF | March 2020 | April 2022 | Abandon | 24 | 2 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HUH, VYNN V.
With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner HUH, VYNN V works in Art Unit 3792 and has examined 208 patent applications in our dataset. With an allowance rate of 63.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.
Examiner HUH, VYNN V's allowance rate of 63.9% places them in the 24% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HUH, VYNN V receive 3.09 office actions before reaching final disposition. This places the examiner in the 88% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by HUH, VYNN V is 40 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +38.5% benefit to allowance rate for applications examined by HUH, VYNN V. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 19.8% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 15.8% of cases where such amendments are filed. This entry rate is in the 17% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 69.2% of appeals filed. This is in the 56% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 47.1% are granted (fully or in part). This grant rate is in the 42% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.